Imatinib: Aggressive systemic mastocytosis medication

Indianpharma10 Mar, 2022Health

Healthcare professionals recommend using the drug Imatinib for treating patients with chronic myeloid leukemia, acute lymphoblastic leukemia, myelodysplastic/myeloproliferative diseases, aggressive systemic mastocytosis, dermatofibrosarcoma protuberans, gastrointestinal stromal tumors, etc. The active ingredient in the medicine is Imatinib mesylate, and inactive ingredients are colloidal silicon dioxide, crospovidone, hydroxypropyl methylcellulose, magnesium stearate, and microcrystalline cellulose. Imatinib mesylate price is economical, and it is easily available with several generic medicine suppliers, for more queries, dial 18008891064.